RecruitingNCT01351545
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Studying Aplastic Anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Principal Investigator
- Heather Stefanski, MD, PhDNMDP/CIBMTR
- Intervention
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)(drug)
- Enrollment
- 99999 enrolled
- Eligibility
- All sexes
- Timeline
- 2011 – 2041
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Mayo Clinic Arizona (adults), Phoenix, Arizona, United States
- University of Arizona Medical Center - Tucson, Tucson, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- City of Hope, Duarte, California, United States
- Children's Hospital of Los Angeles, Glendale, California, United States
- Scripps Green Hospital, La Jolla, California, United States
- University of California San Diego, La Jolla, California, United States
- Loma Linda University Cancer Center, Loma Linda, California, United States
- UCLA, Los Angeles, California, United States
- Children's Hospital and Research Center of Oakland, Oakland, California, United States
- Children's Hospital of Orange County (CHOC), Orange, California, United States
- Sutter Medical Center, Sacramento, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Marrow Donor Program
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01351545 on ClinicalTrials.govOther trials for Aplastic Anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07461116Adverse Effects of ATG/ALG Therapy in Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT07400341Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AAThe First Affiliated Hospital of Soochow University
- RECRUITINGNANCT07101770A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital
- RECRUITINGNANCT07499284A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT06752694Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic AnemiaFred Hutchinson Cancer Center
- RECRUITINGPHASE1NCT06622694CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT06517641Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic AnemiaMedical College of Wisconsin
- RECRUITINGNANCT06936930Reproductive and Mental Health of Patients With Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China